HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The Association of Body Mass Index and 20-Year All-Cause Mortality Among Patients With Stable Coronary Artery Disease.

AbstractBACKGROUND:
Limited data exist regarding the long-term association of body mass index (BMI) and all-cause mortality among patients with stable coronary artery disease (CAD). Accordingly, the aim of this study is to explore the association between BMI and long-term all-cause mortality among patients with stable CAD.
METHODS:
Our study included 15,357 patients with stable CAD who were enrolled in the Bezafibrate Infarction Prevention (BIP) registry between February, 1990 and October1992, and subsequently followed-up through December 2014.
RESULTS:
5,051 (33%) patients were classified as normal weight (BMI 18.5-24.99kg/m2), while 7,841 (51%) patients were classified as overweight (BMI 25-29.99kg/m2), and 2,465 (16%) as obese (BMI≥30). Kaplan-Meier survival analysis showed that at 20 years of follow-up the rate of all-cause mortality was significantly higher among obese patients (67%) compared to overweight (61%) and normal weight (61%); log rank p-value for the overall difference <0.001. Multivariable analysis showed that obese patients had an independently 12% greater mortality risk compared to normal weight patients (HR=1.12; 95% CI 1.02-1.23; p=0.02), whereas, overweight patients experienced a similar mortality risk as normal weight patients (HR=0.99; 95% CI 0.92-1.06; p=0.76). The mortality risk associated with obesity was pronounced among patients younger than 65 years (p-value for interaction<0.05).
CONCLUSIONS:
Our findings indicate that obesity is independently associated with increased risk for long-term mortality among patients with stable coronary artery disease, whereas overweight does not appear to confer an additional risk in this population.
AuthorsAnan Younis, Arwa Younis, Ronen Goldkorn, Ilan Goldenberg, Yael Peled, Boaz Tzur, Robert Klempfner
JournalHeart, lung & circulation (Heart Lung Circ) Vol. 28 Issue 5 Pg. 719-726 (May 2019) ISSN: 1444-2892 [Electronic] Australia
PMID29581037 (Publication Type: Journal Article, Multicenter Study, Randomized Controlled Trial)
CopyrightCopyright © 2018 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V. All rights reserved.
Chemical References
  • Hypolipidemic Agents
  • Bezafibrate
Topics
  • Bezafibrate (therapeutic use)
  • Body Mass Index
  • Cause of Death (trends)
  • Coronary Artery Disease (etiology, mortality, prevention & control)
  • Female
  • Follow-Up Studies
  • Forecasting
  • Humans
  • Hypolipidemic Agents (therapeutic use)
  • Israel (epidemiology)
  • Male
  • Middle Aged
  • Obesity (complications, epidemiology, physiopathology)
  • Population Surveillance
  • Prospective Studies
  • Registries
  • Survival Rate (trends)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: